-
GLP-1s are different for older adults
Part 1 of this story looked at changes to the BRIDGE and BALANCE programs, CMS initiatives that were developed to give Medicare and Medicaid beneficiaries access to GLP-1 treatment for obesity. CMS paused the BALANCE program on April 20, citing lack of insurer participation. The agency is instead extending its Medicare GLP-1 Bridge pilot program…
-
Medicare and Medicaid will cover weight-loss drugs next year
Many people on Medicare and Medicaid who wanted to take GLP-1 drugs for weight loss but couldn’t afford the high prices of these medications were awaiting the launch of the CMS BALANCE Model in 2027. Those Medicare and Medicaid members were waiting because CMS pays for certain GLP-1s to treat diabetes and heart disease, but…
-
What eating disorder experts want journalists to know about GLP-1s
From “Ozempic face” to the latest celebrity confession, there’s no shortage of news about GLP-1s, which has become a catchall term for injectable diabetes and weight-loss drugs like Ozempic, Wegovy and Zepbound. Journalists (including yours truly) have covered the medications’ potential to curb other addictions, their peril in relationships, their controversial use among adolescents, their…
Got any book recommendations?